Your browser doesn't support javascript.
loading
Heavy antiretroviral exposure and exhausted/limited antiretroviral options: predictors and clinical outcomes.
Mocroft, Amanda; Pelchen-Matthews, Annegret; Hoy, Jennifer; Llibre, Josep M; Neesgaard, Bastian; Jaschinski, Nadine; Domingo, Pere; Rasmussen, Line Dahlerup; Günthard, Huldrych F; Surial, Bernard; Öllinger, Angela; Knappik, Michael; de Wit, Stephane; Wit, Ferdinand; Mussini, Cristina; Vehreschild, Joerg; Monforte, Antonella D'Arminio; Sonnerborg, Anders; Castagna, Antonella; Anne, Alain Volny; Vannappagari, Vani; Cohen, Cal; Greaves, Wayne; Wasmuth, Jan C; Spagnuolo, Vincenzo; Ryom, Lene.
Afiliação
  • Mocroft A; CHIP, Section 2100, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Pelchen-Matthews A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, University College London, London, UK.
  • Hoy J; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, University College London, London, UK.
  • Llibre JM; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
  • Neesgaard B; Department of Infectious Diseases, Hospital Universitari Germans Trias i Pujol.
  • Jaschinski N; CHIP, Section 2100, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Domingo P; CHIP, Section 2100, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Rasmussen LD; Department of Infectious Diseases, Hospital of the Holy Cross and Saint Paul, Barcelona, Spain.
  • Günthard HF; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
  • Surial B; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich.
  • Öllinger A; Institute of Medical Virology, University of Zurich, Zurich.
  • Knappik M; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • de Wit S; Department of Dermatology and Venerology, Kepler University Hospital, Linz.
  • Wit F; Department of Respiratory Medicine, Klinik Penzing, Vienna, Austria.
  • Mussini C; CHU Saint-Pierre, Centre de Recherche en Maladies Infectieuses a.s.b.l., Brussels, Belgium.
  • Vehreschild J; AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort, HIV Monitoring Foundation, Amsterdam, the Netherlands.
  • Monforte AD; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy.
  • Sonnerborg A; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Castagna A; Italian Cohort Naive Antiretrovirals (ICONA), ASST Santi Paolo e Carlo, Milan, Italy.
  • Anne AV; Swedish InfCare HIV Cohort, Karolinska University Hospital, Karolinska, Sweden.
  • Vannappagari V; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milan, Italy.
  • Cohen C; European AIDS Treatment Group.
  • Greaves W; ViiV Healthcare, RTP, USA.
  • Wasmuth JC; Gilead Sciences, Foster City, USA.
  • Spagnuolo V; Merck, USA.
  • Ryom L; University Hospital Bonn, Bonn, Germany.
AIDS ; 38(4): 497-508, 2024 Mar 15.
Article em En | MEDLINE | ID: mdl-38079588

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Infecções por HIV / Fármacos Anti-HIV / Insuficiência Renal Crônica Limite: Humans Idioma: En Revista: AIDS Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Infecções por HIV / Fármacos Anti-HIV / Insuficiência Renal Crônica Limite: Humans Idioma: En Revista: AIDS Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: Reino Unido